Dosing and individualized treatment - patient-centric treatment: changing practice guidelines.
作者信息
Patwa H S
机构信息
Yale School of Medicine, New Haven, CT, USA.
出版信息
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):36-8. doi: 10.1111/cei.12503.
Abstract
摘要
相似文献
1
Dosing and individualized treatment - patient-centric treatment: changing practice guidelines.给药与个体化治疗——以患者为中心的治疗：改变实践指南
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):36-8. doi: 10.1111/cei.12503.
2
First-line treatment for CIDP: a new piece of the puzzle.慢性炎性脱髓鞘性多发性神经病的一线治疗：拼图中的新板块。
Lancet Neurol. 2012 Jun;11(6):478-9. doi: 10.1016/S1474-4422(12)70101-1. Epub 2012 May 10.
3
Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy.静脉注射免疫球蛋白（IVIG）治疗慢性脱髓鞘性多发性神经根神经病
Acta Neurol Belg. 2001 Sep;101(3):147-51.
4
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经根神经病：ICE试验
Expert Rev Neurother. 2009 Jun;9(6):789-95. doi: 10.1586/ern.09.30.
5
Evolution and treatment of childhood chronic inflammatory polyneuropathy.儿童慢性炎性多发性神经病的演变与治疗
Pediatr Neurol. 2007 Feb;36(2):88-94. doi: 10.1016/j.pediatrneurol.2006.09.012.
6
High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.高剂量静脉注射免疫球蛋白疗法治疗免疫性神经病
Neurol Sci. 2002 Apr;23 Suppl 1:S25-32. doi: 10.1007/s100720200012.
7
Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.欧洲神经科学学会联合会/周围神经学会关于慢性炎症性脱髓鞘性多发性神经根神经病管理指南的评论
J Peripher Nerv Syst. 2006 Mar;11(1):88-9; author reply 90-1. doi: 10.1111/j.1085-9489.2006.00068.x.
8
Clinical reasoning: a 40-year-old man with CIDP-like illness resistant to treatment.临床推理：一位 40 岁男性，患有 CIDP 样疾病，治疗抵抗。
Neurology. 2013 Sep 3;81(10):e65-70. doi: 10.1212/WNL.0b013e3182a3523b.
9
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.最小临床重要差异分析证实了IgPro10在慢性炎症性脱髓鞘性多发性神经病（CIDP）中的疗效：PRIMA试验。
J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204.
10
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.一种针对慢性炎性神经病中人类免疫球蛋白个体化给药的拟议给药算法。
J Peripher Nerv Syst. 2016 Mar;21(1):33-7. doi: 10.1111/jns.12158.
引用本文的文献
1
Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.大剂量免疫球蛋白在儿童中的抗炎和免疫调节作用：从批准的适应证到超适应证使用。
Cells. 2023 Oct 7;12(19):2417. doi: 10.3390/cells12192417.
2
Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome.静脉注射免疫球蛋白治疗格林-巴利综合征患者的群体药代动力学模型。
Clin Pharmacokinet. 2022 Sep;61(9):1285-1296. doi: 10.1007/s40262-022-01136-z. Epub 2022 Jul 4.
3
Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy.随机对照试验静脉注射免疫球蛋白维持治疗方案在慢性炎症性脱髓鞘性多发性神经根神经病。
Eur J Neurol. 2021 Jan;28(1):286-296. doi: 10.1111/ene.14501. Epub 2020 Oct 1.
本文引用的文献
1
Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.静脉注射免疫球蛋白在多发性运动神经病中的药代动力学。
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1145-8. doi: 10.1136/jnnp-2013-306227. Epub 2013 Dec 11.
2
Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement.通过握力测量评估慢性炎症性脱髓鞘性多发性神经病的静脉注射免疫球蛋白的优化。
Eur Neurol. 2013;70(1-2):65-9. doi: 10.1159/000350287. Epub 2013 Jun 19.
3
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经病患者的血清 IgG 水平。
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):859-61. doi: 10.1136/jnnp-2012-304670. Epub 2013 Mar 28.
4
Comparison of American and European practices in the management of patients with primary immunodeficiencies.原发性免疫缺陷病患者管理的美国与欧洲实践比较。
Clin Exp Immunol. 2012 Jul;169(1):57-69. doi: 10.1111/j.1365-2249.2012.04588.x.
5
Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.循证指南：静脉注射免疫球蛋白治疗神经肌肉疾病：美国神经病学学会治疗学和技术评估小组委员会的报告。
Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293.
6
Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.原发性免疫缺陷病的 IgG 替代治疗选择：皮下 IgG 与静脉内 IgG 及选择最佳剂量。
Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):532-8. doi: 10.1097/ACI.0b013e32834c22da.
7
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.欧洲神经病学会联合会/周围神经学会多发性运动神经病管理指南。欧洲神经病学会联合会和周围神经学会联合工作组的报告——第一次修订版。
J Peripher Nerv Syst. 2010 Dec;15(4):295-301. doi: 10.1111/j.1529-8027.2010.00290.x.
8
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.欧洲神经病学会联合会/周围神经学会关于慢性炎症性脱髓鞘性多发性神经病管理指南：欧洲神经病学会联合会和周围神经学会联合工作组的报告-第一版修订。
Eur J Neurol. 2010 Mar;17(3):356-63. doi: 10.1111/j.1468-1331.2009.02930.x.
9
Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.免疫调节疗法以达到最大疗效：剂量、监测、依从性和在家自注。
J Clin Immunol. 2010 May;30 Suppl 1:S84-9. doi: 10.1007/s10875-010-9400-y.
10
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.静脉注射免疫球蛋白的药代动力学与吉兰-巴雷综合征的预后
Ann Neurol. 2009 Nov;66(5):597-603. doi: 10.1002/ana.21737.
Zotero 插件